NOW LIVE: Eyewitness News
FDA Panel Overwhelmingly Backs Approval Of Anti-Obesity Pill A panel of advisers to the Food and Drug Administration overwhelmingly backed approval for a highly anticipated anti-obesity pill from Vivus Inc., a drug which the FDA previously rejected due to safety concerns.

More From CBS Philly

Win a Trip to Las Vegas To See Britney Spears
GRAMMY’s Fly Away Trip To LA
Best 24 Hour Diners In Philadelphia

Listen Live